- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Anthera Pharmaceuticals Inc
+ Add to WatchlistANTH:US
0.5760 USD 0.0060 1.05%As of 20:10:00 ET on 06/18/2013.
Snapshot for Anthera Pharmaceuticals Inc (ANTH)
| Open: | 0.5700 | Day's Range: | 0.5550 - 0.5845 | Volume: | 169,895 |
|---|---|---|---|---|---|
| Previous Close: | 0.5700 | 52wk Range: | 0.4901 - 3.2100 | 1-Yr Rtn: | -77.05% |
Key Statistics for ANTH
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.7700 |
| Est. EPS (USD) (12/2013) | -0.2320 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 87.91 |
| Shares Outstanding (M) | 152.62 |
| 30 Day Average Volume | 724,679 |
| Price/Book (mrq) | 1.3669 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ANTH
Company Profile & Key Executives for ANTH
Anthera Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing anti-inflammatory therapeutics for cardiovascular diseases, lupus and other serious diseases.
| Christopher S HenneyChairman | Paul F TruexPresident/CEO/Founder |
| Christopher P Lowe "Chris"CFO/Chief Business Officer | Debra OdinkSenior VP/CTO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ANTH News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page